The historic India-UK Free Trade Agreement (FTA) signed on Thursday will radically boost bilateral trade, particularly in the pharma and medical devices sector, said industry experts.
.jpeg)
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received tentative approval from the United States Food and Drug Administration (USFDA) for Ibrutinib tablets 140 mg, 280 mg, and 420 mg (USRLD
Dr Reddy's Laboratories is poised to launch a lower-cost generic version of Novo Nordisk's obesity drug Wegovy (semaglutide) in 87 markets from next year.
In a courtroom defeat for Zydus Lifesciences, the Delhi High Court has stayed the company from marketing its proposed biosimilar of the cancer drug Nivolumab
Some of the latest trends that will steer the market include omnichannel marketing, emotional branding, regulatory first storytelling, and digital asset optimization
India saved ?1,362 crore in pharma raw material imports due to strategic investment under the PLI Scheme for Bulk Drugs, the government told Parliament on Tuesday.
India's burgeoning heart disease burden is not only seen in melodramatized reports of cardiac arrests of young heroes but also in a frightening 50% five-year jump in sales of cardiovascular medicines.
Torrent Pharmaceuticals has sought the Competition Commission of India (CCI) clearance for its planned ?19,500 crore acquisition of a majority holding in JB Chemicals & Pharmaceuticals.
Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading research-driven pharmaceutical company, has once again received the World Health Organization (WHO) Good Distribution Practices (GDP)
The Central Drugs Standard Control Organisation (CDSCO) further prolonged the deadline for pharma firms to file online applications for the WHO Good Manufacturing Practices (GMP) Certificate of Pharmaceutical Product (COPP) to August 15, 2025.
.jpg)
, CDSCO.jpg)